Tiziana Life Sciences PLC PDMR dealings (4766A)

TIDMTILS

RNS Number : 4766A

Tiziana Life Sciences PLC

12 September 2018

For immediate release 12 September 2018

Tiziana Life Sciences plc

(Incorporated in England and Wales with company number 09665181)

PDMR dealings

Tiziana Life Sciences plc (LSE: TILS) (the "Company") announces that on 10 September 2018, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought shares in the Company as follows:

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

 
 1.   Details of PDMR / person closely associated 
 a)   Name                                   Gabriele Cerrone/Panetta Partners 
                                              Limited 
     -------------------------------------  ---------------------------------- 
 2.   Reason for the notification: On market acquisition 
     ------------------------------------------------------------------------- 
 a)   Position / status                      Executive Chairman 
     -------------------------------------  ---------------------------------- 
 b)   Initial notification /amendment        Initial notification 
     -------------------------------------  ---------------------------------- 
 3.   Details of the issuer 
     ------------------------------------------------------------------------- 
 a)   Name                                   Tiziana Life Sciences plc 
     -------------------------------------  ---------------------------------- 
 b)   LEI                                    213800CED47HI8PIOB36 
     -------------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------------- 
 a)   Description of the financial           Ordinary Shares of nominal 
       instrument                             value 3p each 
     -------------------------------------  ---------------------------------- 
 b)   Identification code of the Financial   ISIN for Tiziana Life Sciences 
       Instrument                             plc: GB00BKWNZY55 
     -------------------------------------  ---------------------------------- 
 c)   Nature of the transaction              Acquisition of shares 
     -------------------------------------  ---------------------------------- 
 d)   Price(s) and volume(s) 
                                              Price: GBP1.05; Volume: 1,000 
     -------------------------------------  ---------------------------------- 
 e)   Aggregated information 
       - Aggregated volume                     1,000 
       - Price                                 GBP1,050 
     -------------------------------------  ---------------------------------- 
 f)   Date of the transaction                10 September 2018 
     -------------------------------------  ---------------------------------- 
 g)   Place of the transaction               XLON 
     -------------------------------------  ---------------------------------- 
 

As a result of this transaction Mr Cerrone's interests in the shares of the Company increases from 64,179,170 (50.56%) to 64,180,170 (50.56%). Mr Cerrone's interests in the shares of the Company are based on a holding of 63,680,404 shares held by Planwise Limited and 499,766 shares held by Panetta Partners Limited. Mr Cerrone is considered beneficially interested in the holdings of Panetta Partners Limited and Planwise Limited.

For more information go to http://www.tizianalifesciences.com

Contacts:

 
 
  Tiziana Life Sciences plc 
  Gabriele Cerrone, Chairman and founder     [phone] 
Cairn Financial Advisers LLP (Nominated 
 adviser) 
 Liam Murray / Jo Turner                   [phone] 
Stockdale Securities (Broker) 
 Antonio Bossi / Andy Crossley             [phone] 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHSFWFWFFASEDU

(END) Dow Jones Newswires

September 12, 2018 02:01 ET (06:01 GMT)